Ironwood Pharmaceuticals, Inc. (IRWD)
NASDAQ: IRWD · Real-Time Price · USD
4.120
-0.090 (-2.14%)
Jul 1, 2026, 4:00 PM EDT - Market closed
Ironwood Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 361.51 | 296.15 | 351.41 | 442.74 | 410.6 | 413.75 | |
Revenue Growth (YoY) | 13.80% | -15.72% | -20.63% | 7.83% | -0.76% | 6.22% |
Gross Profit | 361.51 | 296.15 | 351.41 | 442.74 | 410.6 | 413.75 |
Selling, General & Admin | 70.03 | 82.26 | 144.27 | 158.31 | 115.99 | 111.13 |
Research & Development | 89.64 | 95.14 | 111.42 | 116.09 | 44.27 | 70.41 |
Other Operating Expenses | 1.66 | 20.26 | 2.59 | 1,114 | - | -0.04 |
Total Operating Expenses | 161.33 | 197.65 | 258.29 | 1,388 | 160.26 | 181.49 |
Operating Income | 200.18 | 98.5 | 93.12 | -945.43 | 250.34 | 232.26 |
Interest Income | 4.91 | 4.08 | 4.47 | 18.97 | 9.5 | 0.73 |
Interest Expense | -33.82 | -32.75 | -33.03 | -21.63 | -7.6 | -31.15 |
Other Non-Operating Income (Expense) | -28.52 | -28.28 | -27.29 | -2.62 | 2.27 | -32.78 |
Total Non-Operating Income (Expense) | -57.43 | -56.95 | -55.85 | -5.28 | 4.17 | -63.2 |
Pretax Income | 171.47 | 70.03 | 65.2 | -948.07 | 252.42 | 200.66 |
Provision for Income Taxes | -69.29 | -46.01 | -64.32 | -83.49 | -77.36 | 327.79 |
Net Income | 240.76 | 116.03 | 129.52 | -864.58 | 329.78 | -127.13 |
Minority Interest in Earnings | - | - | - | -29.32 | - | - |
Net Income to Common | 102.18 | 24.02 | 0.88 | -2,034 | 350.13 | 1,057 |
Net Income Growth | - | 2629.20% | - | - | -66.87% | 895.42% |
Shares Outstanding (Basic) | 162 | 162 | 159 | 155 | 154 | 162 |
Shares Outstanding (Diluted) | 171 | 163 | 160 | 155 | 186 | 164 |
Shares Change (YoY) | 6.73% | 1.81% | 2.99% | -16.57% | 13.32% | 2.34% |
EPS (Basic) | 0.64 | 0.15 | 0.01 | -6.45 | 1.13 | 3.26 |
EPS (Diluted) | 0.60 | 0.15 | 0.01 | -6.45 | 0.96 | 3.21 |
EPS Growth | - | 1400.00% | - | - | -70.09% | 386.36% |
Free Cash Flow | 112.21 | 127.01 | 103.41 | 183.15 | 273.63 | 261.63 |
Free Cash Flow Growth | -11.65% | 22.82% | -43.54% | -33.06% | 4.58% | 56.67% |
Free Cash Flow Per Share | 0.66 | 0.78 | 0.65 | 1.18 | 1.47 | 1.59 |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Operating Margin | 55.37% | 33.26% | 26.50% | -213.54% | 60.97% | 56.13% |
Profit Margin | 66.60% | 39.18% | 36.86% | -195.28% | 80.32% | -30.73% |
FCF Margin | 31.04% | 42.89% | 29.43% | 41.37% | 66.64% | 63.23% |
EBITDA | 202.03 | 100.38 | 95.14 | -943.86 | 251.76 | 233.78 |
EBITDA Margin | 55.88% | 33.90% | 27.07% | -213.19% | 61.31% | 56.50% |
EBIT | 200.18 | 98.5 | 93.12 | -945.43 | 250.34 | 232.26 |
EBIT Margin | 55.37% | 33.26% | 26.50% | -213.54% | 60.97% | 56.13% |
Effective Tax Rate | -40.41% | -65.70% | -98.65% | 8.81% | -30.65% | 163.36% |